BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Merck & Co., Inc. (MRK) to Close Inspire Pharmaceuticals, Inc. (ISPH) Facility, 51 Jobs Axed


7/1/2011 7:23:06 AM

Pharmaceutical giant Merck, which recently completed its $430 million acquisition of Inspire Pharmaceuticals, is closing that company's Raleigh headquarters Aug. 31 and eliminating 51 jobs. Merck notified North Carolina officials Wednesday of its plans to shut down the headquarters. "The entire facility is to be closed," Merck wrote in the letter to the N.C. Department of Commerce. Last month, Merck said it planned to close Inspire's local headquarters before the end of the year. At that time, the company had about 60 workers in Raleigh. Merck bought Inspire to expand its lineup of treatments for eye ailments.

Read at newsobserver.com
Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES